This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
Admission to Listing Announcement:- NeoMedigen Limited Change of Name from NeoMedigen, Inc.
HAMILTON, BERMUDA: 27 May 2013 - The Bermuda Stock Exchange announces the change of name of NeoMedigen, Inc. (“the Company”), to NeoMedigen Limited (“the Company”) as the Company has restructured by continuance into Bermuda. The Company was continued to Bermuda under its present name, NeoMedigen Limited, on 24 April, 2013 bearing registration number 47643 as evidenced by a Certificate of Continuance issued by the Registrar of Companies in Bermuda on 7 May 2013. The Company’s listed share capital on the BSX is as follows:
· Name of Issuer:- NeoMedigen Limited
· Description of Securities: - Common Shares of US$0.00001 par value, fully paid.
· Nominal Amount of Securities:- 25,000,000 Common Shares.
· Listing Classification:- Section IIIA – International Issuers of Equity Securities, granted waiver from Qualified Investor restriction by granting of Section IIIA, 4.10 Waiver; reporting under Section IIA, Chapter 6.
· Method of Listing:- Introduction (Following restructuring and corporate continuance into Bermuda).
· Date of Admission to Listing under the continuance:- Monday, 27 May, 2013.
· Listing Sponsor:- Butterfield Securities (Bermuda) Limited.